Early occurrence and prognostic significance of p53 alteration in primary carcinoma of the fallopian tube

Wenxin - Zheng, C. James Sung, Peiqin Cao, Zuo Feng Zhang, Ruya Cai, Thomas A. Godwin, Elmer E. Kramer, Stuart C. Lauchlan

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

The pathogenesis of primary carcinoma of the fallopian tube (PCFT) is poorly understood. Tumor suppressor p53 gene alterations are common in human malignancies, but their role in the tumorigenesis and survival of PCFT is undefined. The objectives of this study were to define the occurrence and prognostic rule of p53 alteration in PCFT and to examine the efficiency of immunohistochemistry (IHC) in detecting p53 alteration in PCFT. Fifty-two PCFT and 10 normal fallopian tubes were examined for p53 alteration by IHC and polymerase chain reaction-single-strand conformation polymorphism (PCR- SSCP). The Kaplan-Meier method was used to derive the survival function, while the log-rank test was used to compare curves for two or more groups. Other patients' characteristics were analyzed by two-tailed Fisher's exact tests. IHC correlated well with PCR-SSCP with 100% sensitivity and 83.3% specificity for detecting p53 alteration in this study. Thirty-one of 52 (57%) PCFT showed p53 alteration. Alteration of p53 occurred in all stages of PCFT with a similar incidence in carcinoma in situ and late-stage disease. Alteration of p53 was related to tumor histologic type. Significant survival difference was noted between advanced and early clinical stages but no such difference was identified among different tumor grades. Compared to the p53- nonaltered group, the presence of p53 alteration in PCFT was related to significantly decreased patient survival (RR = 6.8, 95% CI = 2.9-16.2) in multivariate analysis. In the subgroup of patients with residual tumor after surgery, those with p53-altered tumors had a significantly decreased survival compared to those with p53-nonaltered group (RR = 7.4, 95% CI = 1.9-28.2). Alteration of p53 is common and IHC is an efficient method to detect p53 alteration in PCFT. Shorter survival is associated with p53 alteration which is an independent marker for the disease in this study. Alteration of p53 may be an early event in tubal tumorigenesis and may play an important role in the development of PCFT. Whether detection of p53 alteration may serve as an indicator of high-risk patients for whom more aggressive adjuvant chemotherapy may be considered needs to be explored in the future.

Original languageEnglish (US)
Pages (from-to)38-48
Number of pages11
JournalGynecologic Oncology
Volume64
Issue number1
DOIs
StatePublished - Jan 1997
Externally publishedYes

Fingerprint

Fallopian Tubes
Carcinoma
Survival
Immunohistochemistry
Neoplasms
Carcinogenesis
Single-Stranded Conformational Polymorphism
Polymerase Chain Reaction
p53 Genes
Carcinoma in Situ
Residual Neoplasm
Adjuvant Chemotherapy
Tumor Suppressor Genes
Multivariate Analysis

ASJC Scopus subject areas

  • Obstetrics and Gynecology
  • Oncology

Cite this

Early occurrence and prognostic significance of p53 alteration in primary carcinoma of the fallopian tube. / Zheng, Wenxin -; Sung, C. James; Cao, Peiqin; Zhang, Zuo Feng; Cai, Ruya; Godwin, Thomas A.; Kramer, Elmer E.; Lauchlan, Stuart C.

In: Gynecologic Oncology, Vol. 64, No. 1, 01.1997, p. 38-48.

Research output: Contribution to journalArticle

Zheng, W, Sung, CJ, Cao, P, Zhang, ZF, Cai, R, Godwin, TA, Kramer, EE & Lauchlan, SC 1997, 'Early occurrence and prognostic significance of p53 alteration in primary carcinoma of the fallopian tube', Gynecologic Oncology, vol. 64, no. 1, pp. 38-48. https://doi.org/10.1006/gyno.1996.4519
Zheng, Wenxin - ; Sung, C. James ; Cao, Peiqin ; Zhang, Zuo Feng ; Cai, Ruya ; Godwin, Thomas A. ; Kramer, Elmer E. ; Lauchlan, Stuart C. / Early occurrence and prognostic significance of p53 alteration in primary carcinoma of the fallopian tube. In: Gynecologic Oncology. 1997 ; Vol. 64, No. 1. pp. 38-48.
@article{cd62892141b64abe97477dc7e6ddb0ac,
title = "Early occurrence and prognostic significance of p53 alteration in primary carcinoma of the fallopian tube",
abstract = "The pathogenesis of primary carcinoma of the fallopian tube (PCFT) is poorly understood. Tumor suppressor p53 gene alterations are common in human malignancies, but their role in the tumorigenesis and survival of PCFT is undefined. The objectives of this study were to define the occurrence and prognostic rule of p53 alteration in PCFT and to examine the efficiency of immunohistochemistry (IHC) in detecting p53 alteration in PCFT. Fifty-two PCFT and 10 normal fallopian tubes were examined for p53 alteration by IHC and polymerase chain reaction-single-strand conformation polymorphism (PCR- SSCP). The Kaplan-Meier method was used to derive the survival function, while the log-rank test was used to compare curves for two or more groups. Other patients' characteristics were analyzed by two-tailed Fisher's exact tests. IHC correlated well with PCR-SSCP with 100{\%} sensitivity and 83.3{\%} specificity for detecting p53 alteration in this study. Thirty-one of 52 (57{\%}) PCFT showed p53 alteration. Alteration of p53 occurred in all stages of PCFT with a similar incidence in carcinoma in situ and late-stage disease. Alteration of p53 was related to tumor histologic type. Significant survival difference was noted between advanced and early clinical stages but no such difference was identified among different tumor grades. Compared to the p53- nonaltered group, the presence of p53 alteration in PCFT was related to significantly decreased patient survival (RR = 6.8, 95{\%} CI = 2.9-16.2) in multivariate analysis. In the subgroup of patients with residual tumor after surgery, those with p53-altered tumors had a significantly decreased survival compared to those with p53-nonaltered group (RR = 7.4, 95{\%} CI = 1.9-28.2). Alteration of p53 is common and IHC is an efficient method to detect p53 alteration in PCFT. Shorter survival is associated with p53 alteration which is an independent marker for the disease in this study. Alteration of p53 may be an early event in tubal tumorigenesis and may play an important role in the development of PCFT. Whether detection of p53 alteration may serve as an indicator of high-risk patients for whom more aggressive adjuvant chemotherapy may be considered needs to be explored in the future.",
author = "Zheng, {Wenxin -} and Sung, {C. James} and Peiqin Cao and Zhang, {Zuo Feng} and Ruya Cai and Godwin, {Thomas A.} and Kramer, {Elmer E.} and Lauchlan, {Stuart C.}",
year = "1997",
month = "1",
doi = "10.1006/gyno.1996.4519",
language = "English (US)",
volume = "64",
pages = "38--48",
journal = "Gynecologic Oncology",
issn = "0090-8258",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Early occurrence and prognostic significance of p53 alteration in primary carcinoma of the fallopian tube

AU - Zheng, Wenxin -

AU - Sung, C. James

AU - Cao, Peiqin

AU - Zhang, Zuo Feng

AU - Cai, Ruya

AU - Godwin, Thomas A.

AU - Kramer, Elmer E.

AU - Lauchlan, Stuart C.

PY - 1997/1

Y1 - 1997/1

N2 - The pathogenesis of primary carcinoma of the fallopian tube (PCFT) is poorly understood. Tumor suppressor p53 gene alterations are common in human malignancies, but their role in the tumorigenesis and survival of PCFT is undefined. The objectives of this study were to define the occurrence and prognostic rule of p53 alteration in PCFT and to examine the efficiency of immunohistochemistry (IHC) in detecting p53 alteration in PCFT. Fifty-two PCFT and 10 normal fallopian tubes were examined for p53 alteration by IHC and polymerase chain reaction-single-strand conformation polymorphism (PCR- SSCP). The Kaplan-Meier method was used to derive the survival function, while the log-rank test was used to compare curves for two or more groups. Other patients' characteristics were analyzed by two-tailed Fisher's exact tests. IHC correlated well with PCR-SSCP with 100% sensitivity and 83.3% specificity for detecting p53 alteration in this study. Thirty-one of 52 (57%) PCFT showed p53 alteration. Alteration of p53 occurred in all stages of PCFT with a similar incidence in carcinoma in situ and late-stage disease. Alteration of p53 was related to tumor histologic type. Significant survival difference was noted between advanced and early clinical stages but no such difference was identified among different tumor grades. Compared to the p53- nonaltered group, the presence of p53 alteration in PCFT was related to significantly decreased patient survival (RR = 6.8, 95% CI = 2.9-16.2) in multivariate analysis. In the subgroup of patients with residual tumor after surgery, those with p53-altered tumors had a significantly decreased survival compared to those with p53-nonaltered group (RR = 7.4, 95% CI = 1.9-28.2). Alteration of p53 is common and IHC is an efficient method to detect p53 alteration in PCFT. Shorter survival is associated with p53 alteration which is an independent marker for the disease in this study. Alteration of p53 may be an early event in tubal tumorigenesis and may play an important role in the development of PCFT. Whether detection of p53 alteration may serve as an indicator of high-risk patients for whom more aggressive adjuvant chemotherapy may be considered needs to be explored in the future.

AB - The pathogenesis of primary carcinoma of the fallopian tube (PCFT) is poorly understood. Tumor suppressor p53 gene alterations are common in human malignancies, but their role in the tumorigenesis and survival of PCFT is undefined. The objectives of this study were to define the occurrence and prognostic rule of p53 alteration in PCFT and to examine the efficiency of immunohistochemistry (IHC) in detecting p53 alteration in PCFT. Fifty-two PCFT and 10 normal fallopian tubes were examined for p53 alteration by IHC and polymerase chain reaction-single-strand conformation polymorphism (PCR- SSCP). The Kaplan-Meier method was used to derive the survival function, while the log-rank test was used to compare curves for two or more groups. Other patients' characteristics were analyzed by two-tailed Fisher's exact tests. IHC correlated well with PCR-SSCP with 100% sensitivity and 83.3% specificity for detecting p53 alteration in this study. Thirty-one of 52 (57%) PCFT showed p53 alteration. Alteration of p53 occurred in all stages of PCFT with a similar incidence in carcinoma in situ and late-stage disease. Alteration of p53 was related to tumor histologic type. Significant survival difference was noted between advanced and early clinical stages but no such difference was identified among different tumor grades. Compared to the p53- nonaltered group, the presence of p53 alteration in PCFT was related to significantly decreased patient survival (RR = 6.8, 95% CI = 2.9-16.2) in multivariate analysis. In the subgroup of patients with residual tumor after surgery, those with p53-altered tumors had a significantly decreased survival compared to those with p53-nonaltered group (RR = 7.4, 95% CI = 1.9-28.2). Alteration of p53 is common and IHC is an efficient method to detect p53 alteration in PCFT. Shorter survival is associated with p53 alteration which is an independent marker for the disease in this study. Alteration of p53 may be an early event in tubal tumorigenesis and may play an important role in the development of PCFT. Whether detection of p53 alteration may serve as an indicator of high-risk patients for whom more aggressive adjuvant chemotherapy may be considered needs to be explored in the future.

UR - http://www.scopus.com/inward/record.url?scp=0031031504&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031031504&partnerID=8YFLogxK

U2 - 10.1006/gyno.1996.4519

DO - 10.1006/gyno.1996.4519

M3 - Article

C2 - 8995545

AN - SCOPUS:0031031504

VL - 64

SP - 38

EP - 48

JO - Gynecologic Oncology

JF - Gynecologic Oncology

SN - 0090-8258

IS - 1

ER -